GAF Healthcare

Best Medical Oncologists for Targeted Therapy in Mumbai, India

This page lists 3 targeted therapy doctors in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 3 targeted therapy doctors in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About Targeted Therapy doctors in Mumbai, India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

Targeted Therapy doctors

Image not available Featured

Dr. Jeyhan Dhabhar

MBBS, MD, DNB
Consultant — Medical Oncology and Hemato-Oncology · Specialty: Medical Oncologist and Hemato-Oncologist
Gleneagles Hospital, Mumbai Mumbai, India7+ Years experience
Why consider this doctor?
  • 7+ years of experience in Medical Oncologist and Hemato-Oncologist
  • Consultant Medical Oncologist and Hemato-Oncologist, Gleneagles Hospital, Mumbai, Parel — Present
  • Specialization in Precision Oncology and Cancer Genomics at Gleneagles Hospital, Mumbai — Present
Expertise & Procedures
  • Chemotherapy Administration and Management
  • Targeted Therapy Planning and Delivery
  • Cancer Immunotherapy
  • Hormone Therapy for Breast Cancer
  • Hormone Therapy for Prostate Cancer
View all procedures →
Medical Oncologist and Hemato-Oncologist Experience: 7+ YearsHospital Affiliation: Gleneagles Hospital, MumbaiHospital accreditation: NABH, JCI
View Profile Book a Consultation
Image not available

Dr. Rohit Ramesh Pai

MBBS, MD in Internal Medicine, DM in Medical Oncology, MRCP (UK), MRCP (SCE), DNB in Medical Oncology
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Hospital Mumbai, India10+ Years experience
Why consider this doctor?
  • 10+ years of experience in Medical Oncologist
  • Senior Consultant — Medical Oncology, Gleneagles Hospital, Mumbai
  • Consultant Medical Oncologist, Bombay Hospital, Mumbai
Expertise & Procedures
  • Chemotherapy Administration and Management
  • Cancer Immunotherapy Planning and Delivery
  • Targeted Therapy Selection and Monitoring
  • Hormone Therapy for Breast Cancer
  • Hormone Therapy for Prostate Cancer
View all procedures →
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Gleneagles HospitalHospital accreditation: NABH, JCI
View Profile Book a Consultation
Image not available

Dr. Siddharth W. Turkar

DM, DNB, MBBS
Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospitals Mumbai, India13+ Years experience
Why consider this doctor?
  • 13+ years of experience in Medical Oncologist
  • Consultant — Medical Oncology, Apollo Hospitals, Mumbai, Present
  • 13+ years of clinical experience in comprehensive cancer management
Expertise & Procedures
  • Chemotherapy for solid tumours
  • Neoadjuvant chemotherapy protocols
  • Adjuvant chemotherapy regimens
  • Palliative chemotherapy
  • Immune checkpoint inhibitor therapy
View all procedures →
Medical Oncologist Experience: 13+ YearsHospital Affiliation: Apollo HospitalsHospital accreditation: JCI, NABH
View Profile Book a Consultation

Hospitals where these doctors practise

Gleneagles Global Hospitals (Global Hospitals)🇮🇳 Parel, Mumbai, India
Starting from$300

Gleneagles Global Hospitals (Global Hospitals)

Est. 1996
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
Targeted TherapyMedical OncologyLiver TransplantCardiac Surgery
2+
Doctors for Targeted Therapy
4.6
183 reviews
450+
Beds
30+
Years Since Founded
Dr. Jeyhan DhabharDr. Rohit Ramesh Pai
View Hospital Profile Enquire / Get Free Opinion

Why consider treatment in India?

Many international patients consider India for lung cancer treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is Targeted Therapy?

Targeted therapy uses drugs designed to specifically identify and attack cancer cells based on genetic mutations, proteins, or receptors, while sparing normal healthy cells. It is used across breast, lung, colorectal, gastric, liver, pancreatic, prostate, ovarian, head & neck cancers, leukemia, lymphoma, and multiple myeloma, often guided by biomarker or genomic testing. India offers internationally accredited cancer centres with access to the latest targeted agents at a fraction of Western costs.

Who may be considered?

Targeted Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

3 approaches available for this procedure:

Biomarker/Genomic Testing & Drug Selection

Essential First Step

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

Comprehensive Investigations

Estimated cost: $300 - $1,500

Tumor biopsy, IHC/FISH testing, next-generation sequencing (NGS) panel, liquid biopsy, complete blood count (CBC), liver and kidney function tests

Treatment / Procedure Estimate

Estimated cost in India: $300 - $2,000

Stay in India

Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: 0 days (outpatient)
Recovery period (outside hospital): ~1 day
Total stay: approx 3 days

Usually Included in Hospital Package

  • Oncologist consultation
  • Tissue/blood sample processing
  • Genomic report interpretation
  • Tumor board review

Usually Not Included

  • International shipping of external samples
  • Repeat biopsy if sample inadequate
  • Second confirmatory pathology opinion

Recovery and follow-up

Most patients tolerate targeted therapy on an outpatient or short-stay basis, with periodic monitoring for side effects such as fatigue, skin reactions, or organ toxicity; response is typically reassessed via imaging every 2-3 treatment cycles.

Risks

Potential risks include infusion reactions, cardiotoxicity, skin and gastrointestinal side effects, elevated liver enzymes, and, less commonly, resistance development requiring drug switch.

Alternatives

Depending on cancer type and stage, alternatives may include conventional chemotherapy, immunotherapy, hormonal therapy, radiation, or surgical resection, often used in combination with or instead of targeted therapy.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Histopathology and biopsy report
  • IHC/FISH biomarker results (HER2, ER/PR, etc.)
  • Next-generation sequencing (NGS) or mutation panel report
  • Recent CT/PET-CT/MRI imaging
  • Complete blood count and organ function tests
  • Prior treatment and chemotherapy history
  • Discharge summaries from previous hospitalizations
  • Current medication list

Patient information needed

  • Cancer type, stage, and site of primary tumor
  • Prior treatments including surgery, chemotherapy, radiation
  • Known genetic mutations or biomarker status if tested
  • Current performance status and comorbidities
  • Allergy history, especially to biologic drugs
  • Cardiac history if cardiotoxic drugs are anticipated
  • Insurance or budget considerations
  • Availability of a caregiver/companion during treatment

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (Targeted Therapy) and procedure (Targeted Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about Targeted Therapy in Mumbai, India

What is Lung Cancer?
Lung cancer is a malignant condition in which cells in one or both lungs multiply abnormally, most commonly arising in the cells lining the airways (non-small cell lung cancer) or in neuroendocrine cells of the lung (small cell lung cancer). The distinction between these types, along with the tumour's stage and molecular profile, directly shapes the treatment approach.
What are the symptoms and health risks of Lung Cancer?
Common symptoms include a persistent or worsening cough, coughing up blood, unexplained shortness of breath, chest pain, hoarseness, unintentional weight loss, and recurrent chest infections. As the disease progresses or spreads, symptoms such as bone pain, headache, or swelling in the face and neck may also appear. It is important to note that these symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis.
How is Lung Cancer diagnosed?
Diagnosis typically begins with a detailed clinical history and physical examination, followed by chest X-ray or CT scan to identify suspicious lesions. A tissue biopsy — obtained bronchoscopically, via CT-guided needle, or surgically — is required to confirm the cancer type and, increasingly, to test for specific genetic mutations (such as EGFR, ALK, or PD-L1 expression) that guide targeted therapy decisions. Staging, usually described using the TNM system (Stage I through IV for non-small cell, and limited versus extensive for small cell), along with PET scan and sometimes brain MRI, determines how far the cancer has spread and which treatment pathways are appropriate.
How is Lung Cancer treated?
Treatment depends heavily on the cancer type, stage, molecular markers, and the patient's overall lung function and health status. Early-stage non-small cell lung cancer may be treated with surgery, stereotactic body radiation therapy (SBRT), or a combination of chemotherapy and radiation; advanced stages may involve systemic therapies such as chemotherapy, targeted agents, or immunotherapy, often combined with radiation therapy such as intensity-modulated radiation therapy (IMRT). Small cell lung cancer is generally managed with chemotherapy and radiation, and all decisions about sequencing and combining treatments are made by a multidisciplinary team following individual assessment.
Can Lung Cancer be treated without a procedure?
Non-surgical pathways are well established and clinically significant for lung cancer. Stereotactic body radiation therapy (SBRT) is a recognised standard for early-stage tumours in patients who are not surgical candidates or who prefer to avoid surgery. For locally advanced or metastatic disease, chemotherapy, immunotherapy, targeted molecular therapies, and radiation therapy (including IMRT) form the backbone of treatment — meaning many patients receive effective care without any surgical procedure.
When is Targeted Therapy considered for Lung Cancer?
Targeted Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Lung Cancer?
Lung cancer is typically evaluated and managed by a multidisciplinary team that may include a thoracic oncologist or medical oncologist (who oversees systemic therapies), a radiation oncologist (who plans and delivers SBRT or IMRT), a thoracic surgeon (for surgical cases), and a pulmonologist involved in initial diagnosis. A dedicated lung cancer tumour board — where specialists review each case collectively — is considered best practice at experienced centres.
How do I choose a doctor for Lung Cancer?
When comparing providers, look for centres with a dedicated thoracic or lung cancer programme, access to molecular tumour profiling, and an active multidisciplinary tumour board, as these factors are associated with more personalised and coordinated care. It is also worth asking about the radiation oncology team's specific experience with SBRT and IMRT for lung tumours, the technology available (such as image-guided or motion-management systems), and what structured follow-up and supportive care are offered after treatment.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.
WhatsApp Us